Standardizing initial dilution titers of antinuclear antibodies for the screening of systemic lupus erythematosus

Keyphrases

• Systemic Lupus Erythematosus 100%
• Titer 100%
• Antinuclear Antibodies 100%
• Initial Dilution 100%
• Indirect Immunofluorescence 60%
• Healthy Controls 40%
• Systemic Lupus Erythematosus Patient 40%
• Antinuclear Antibody Positivity 40%
• Clinical Features 20%
• Pathologist 20%
• South India 20%
• Healthy Individuals 20%
• Newly Diagnosed 20%
• Serum Samples 20%
• Rheumatic Diseases 20%
• Population Specificity 20%
• Staining Pattern 20%
• Commercial Kits 20%
• Speckle Pattern 20%
• Systemic Autoimmune Diseases 20%
• Low Dilution 20%
• Agreement Measure 20%
• South Indian Population 20%
• Intensity Pattern 20%

Immunology and Microbiology

• Systemic Lupus Erythematosus 100%
• Antinuclear Antibody 100%
• Titer 100%
• Dilution 100%
• Immunofluorescence 30%
• Systemic Autoimmune Disease 10%
• Staining 10%
• Rheumatic Disease 10%

Biochemistry, Genetics and Molecular Biology

• Dilution 100%
• Titer 100%
• Immunofluorescence 30%
• Prospective Study 10%
• Staining 10%